Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma
Abstract Background The prognosis of hepatocellular carcinoma (HCC) has been extensively studied. However, the impact on prognosis of stage I HCC has not been well studied at clincopathological, mutational and transcriptional levels. Methods Here we first characterized the influencing factors of pro...
Main Authors: | Zhiqiang Li, Hongqiang Gao, Xiang Zhang, Qiyu Liu, Gang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-022-02496-3 |
Similar Items
-
Transcription Factors and Methylation Drive Prognostic miRNA Dysregulation in Hepatocellular Carcinoma
by: Shijie Qin, et al.
Published: (2021-07-01) -
Genetic expression and mutational profile analysis in different pathologic stages of hepatocellular carcinoma patients
by: Xingjie Gao, et al.
Published: (2021-07-01) -
Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
by: Xiaoyi Hu, et al.
Published: (2020-09-01) -
Prognostic and clinicopathological value of Beclin-1 expression in hepatocellular carcinoma: a meta-analysis
by: Zhiqiang Qin, et al.
Published: (2018-08-01) -
Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
by: Xiaoyi Hu, et al.
Published: (2020-11-01)